PHARMAC widens access to funded treatments for multiple sclerosis
12 February 2021 Media release Medicines
PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March. 1800 people with multiple sclerosis will be able to stay on their treatment for longer, and some who had stopped funded treatment may now be eligible to restart.
Multiple sclerosis is a progressive neurological condition that leads to increasing levels of disability. Jeremy Seed (Kai Tahu/ Kati Mamoe) has had multiple sclerosis for eleven years. The former New Zealand Army officer and father of two is relieved that he will be able to stay on his treatment for longer. “It is really good news. The 500 metre walk was an annual stressor, and I was worried each time I would no longer qualify for my medication. Ironically, stress can exacerbate MS, so not having to worry about it is fantastic,” says Jeremy.